Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marisa A Brake

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Thrombosis and Haemostasis : JTH|July 30, 2025
Plasma peptidomics: cutting coagulation down to sizeMarisa A Brake, Sol Schulman
Seminars in Thrombosis and Hemostasis|May 18, 2023
Human Genetic Variation in F3 and Its Impact on Tissue Factor-Dependent DiseaseJin K Park, Marisa A Brake, Sol Schulman
Biorxiv : the Preprint Server for Biology|July 9, 2025
POmAb, an antibody targeting open prothrombin, results in anticoagulation without excessive bleeding in miceMarisa A Brake, Suresh Kumar, Glenn Merrill-Skoloff, et al.
Current Protocols in Mouse Biology|March 16, 2019
Assessing Blood Clotting and Coagulation Factors in MiceMarisa A Brake, Lacramioara Ivanciu, Susan A Maroney, et al.
Blood|October 16, 2025
Human missense variants in F3 impair the initiation of blood coagulationShabbir A Ansari, Marisa A Brake, Nishtha Pathak, et al.
Journal of Thrombosis and Haemostasis : JTH|February 15, 2026
In vivo targeting of open prothrombin with POmAb results in anticoagulation without excessive bleedingMarisa A Brake, Suresh Kumar, Catherine Lapointe, et al.
British Journal of Cancer|December 21, 2021
Intratumoural haematopoietic stem and progenitor cell differentiation into M2 macrophages facilitates the regrowth of solid tumours after radiation therapyTyler M Parsons, Katie L Buelow, Alaa Hanna, et al.
Science Translational Medicine|June 17, 2026
Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17-driven endothelial activationDimitra Karagkouni, Marisa A Brake, Rushad Patell, et al.
The Journal of Clinical Investigation|July 15, 2020
A coagulation defect arising from heterozygous premature termination of tissue factorSol Schulman, Emale El-Darzi, Mary Hc Florido, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
A Sensitized ENU Mutagenesis Screen for Thrombosis Modifiers Identifies Suppressor Variants in Non-mutagenized Parental Generations Due to Antithrombotic Selective PressuresMarisa A Brake, Audrey C Cleuren, Sydney Torres, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Thrombosis and Haemostasis : JTH|July 30, 2025
Plasma peptidomics: cutting coagulation down to sizeMarisa A Brake, Sol Schulman
Seminars in Thrombosis and Hemostasis|May 18, 2023
Human Genetic Variation in F3 and Its Impact on Tissue Factor-Dependent DiseaseJin K Park, Marisa A Brake, Sol Schulman
Biorxiv : the Preprint Server for Biology|July 9, 2025
POmAb, an antibody targeting open prothrombin, results in anticoagulation without excessive bleeding in miceMarisa A Brake, Suresh Kumar, Glenn Merrill-Skoloff, et al.
Current Protocols in Mouse Biology|March 16, 2019
Assessing Blood Clotting and Coagulation Factors in MiceMarisa A Brake, Lacramioara Ivanciu, Susan A Maroney, et al.
Blood|October 16, 2025
Human missense variants in F3 impair the initiation of blood coagulationShabbir A Ansari, Marisa A Brake, Nishtha Pathak, et al.
Journal of Thrombosis and Haemostasis : JTH|February 15, 2026
In vivo targeting of open prothrombin with POmAb results in anticoagulation without excessive bleedingMarisa A Brake, Suresh Kumar, Catherine Lapointe, et al.
British Journal of Cancer|December 21, 2021
Intratumoural haematopoietic stem and progenitor cell differentiation into M2 macrophages facilitates the regrowth of solid tumours after radiation therapyTyler M Parsons, Katie L Buelow, Alaa Hanna, et al.
Science Translational Medicine|June 17, 2026
Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17-driven endothelial activationDimitra Karagkouni, Marisa A Brake, Rushad Patell, et al.
The Journal of Clinical Investigation|July 15, 2020
A coagulation defect arising from heterozygous premature termination of tissue factorSol Schulman, Emale El-Darzi, Mary Hc Florido, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
A Sensitized ENU Mutagenesis Screen for Thrombosis Modifiers Identifies Suppressor Variants in Non-mutagenized Parental Generations Due to Antithrombotic Selective PressuresMarisa A Brake, Audrey C Cleuren, Sydney Torres, et al.
Pageof 2